Cytokinetics, Incorporated CYTK was a big mover last session with its shares nearly 9% on the day. The move came on solid volume with far more shares changing hands yesterday than in a normal session. This breaks the recent trend of the company as the stock is now trading above the past month’s volatile price range of $10.36 to $12.29.
This clinical stage biopharmaceutical company has seen no estimate revision in the last 7 days. The Zacks Consensus Estimate has also remained unchanged over the same period. Yesterday’s rally is encouraging though, so make sure to keep a close watch on this firm in the near future.
Cytokinetics currently has a Zacks Rank #2 (Buy) while its Earnings ESP is negative.
Investors interested in the biomed/gene industry may also consider Actelion Ltd. ALIOF which sports a Zacks Rank #1 (Strong Buy).
Is CYTK going up? Or down? Predict to see what others think: Up or Down
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment